Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinglu Guo

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Journal of Clinical and Experimental Hepatology|April 28, 2025
The Role of Stereotactic Body Radiation Therapy in the Outcomes of Intrahepatic Recurrent Small Hepatocellular CarcinomaYongjie Shui, Dongjun Dai, Yang Yang, et al.
Cancer Research|March 9, 2005
Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancerQiang Zhang, Ximing Yang, Michael Pins, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|August 17, 2004
[In vitro effect of zilongjin on prostate cancer cell line LNCaP]Xue-song Li, Yun-yan Liang, Dai-shu Wang, et al.
BJU International|August 2, 2006
The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitroQiang Zhang, Wei Zhou, Shilajit Kundu, et al.
Urology|September 19, 2015
Low-intensity Pulsed Ultrasound Improves Erectile Function in Streptozotocin-induced Type I Diabetic RatsHongen Lei, Hua Xin, Ruili Guan, et al.
Molecular Pharmaceutics|December 26, 2022
Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma ModelQiyao Yang, Qi Dai, Xiaoyan Bao, et al.
Biochemical and Biophysical Research Communications|May 7, 2013
Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progressionWei He, Xuesong Li, Shuping Xu, et al.
Annals of Translational Medicine|May 14, 2021
Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort studyLin Zheng, Zhi-Rui Zhou, Minghan Shi, et al.
Translational Andrology and Urology|May 19, 2020
Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patientsGang Song, Mingjian Ruan, He Wang, et al.
Molecular Cancer Therapeutics|August 8, 2006
Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycleQiang Zhang, Ximing J Yang, Shilajit D Kundu, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Journal of Clinical and Experimental Hepatology|April 28, 2025
The Role of Stereotactic Body Radiation Therapy in the Outcomes of Intrahepatic Recurrent Small Hepatocellular CarcinomaYongjie Shui, Dongjun Dai, Yang Yang, et al.
Cancer Research|March 9, 2005
Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancerQiang Zhang, Ximing Yang, Michael Pins, et al.
Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi = Chinese Journal of Integrated Traditional and Western Medicine|August 17, 2004
[In vitro effect of zilongjin on prostate cancer cell line LNCaP]Xue-song Li, Yun-yan Liang, Dai-shu Wang, et al.
BJU International|August 2, 2006
The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitroQiang Zhang, Wei Zhou, Shilajit Kundu, et al.
Urology|September 19, 2015
Low-intensity Pulsed Ultrasound Improves Erectile Function in Streptozotocin-induced Type I Diabetic RatsHongen Lei, Hua Xin, Ruili Guan, et al.
Molecular Pharmaceutics|December 26, 2022
Evaluation of a Tumor-Targeting Oligosaccharide Nanosystem in BNCT on an Orthotopic Hepatocellular Carcinoma ModelQiyao Yang, Qi Dai, Xiaoyan Bao, et al.
Biochemical and Biophysical Research Communications|May 7, 2013
Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progressionWei He, Xuesong Li, Shuping Xu, et al.
Annals of Translational Medicine|May 14, 2021
Nomograms for predicting progression-free survival and overall survival after surgery and concurrent chemoradiotherapy for glioblastoma: a retrospective cohort studyLin Zheng, Zhi-Rui Zhou, Minghan Shi, et al.
Translational Andrology and Urology|May 19, 2020
Predictive model using prostate MRI findings can predict candidates for nerve sparing radical prostatectomy among low-intermediate risk prostate cancer patientsGang Song, Mingjian Ruan, He Wang, et al.
Molecular Cancer Therapeutics|August 8, 2006
Blockade of transforming growth factor-{beta} signaling in tumor-reactive CD8(+) T cells activates the antitumor immune response cycleQiang Zhang, Ximing J Yang, Shilajit D Kundu, et al.
Pageof 9